The involvement of the 5-HT(7) receptor in nociception and
pain, particularly
chronic pain (i.e.,
neuropathic pain), has been poorly investigated. In the present study, we examined whether the 5-HT(7) receptor participates in some modulatory control of nerve injury-evoked mechanical
hypersensitivity and thermal (heat)
hyperalgesia in mice. Activation of 5-HT(7) receptors by systemic administration of the selective 5-HT(7) receptor agonist AS-19 (1 and 10mg/kg) exerted a clear-cut reduction of mechanical and thermal
hypersensitivities that were reversed by co-administering the selective 5-HT(7) receptor antagonist
SB-258719. Interestingly, blocking of 5-HT(7) receptors with
SB-258719 (2.5 and 10mg/kg) enhanced mechanical (but not thermal)
hypersensitivity in nerve-injured mice and induced mechanical
hypersensitivity in
sham-operated mice. Effectiveness of the treatment with a 5-HT(7) receptor agonist was maintained after repeated systemic administration: no tolerance to the antiallodynic and antihyperalgesic effects was developed following treatment with the selective 5-HT(7) receptor agonist
E-57431 (10mg/kg) twice daily for 11 days. The 5-HT(7) receptor co-localized with GABAergic cells in the dorsal horn of the spinal cord, suggesting that the activation of spinal inhibitory GABAergic interneurons could contribute to the
analgesic effects of 5-HT(7) receptor agonists. In addition, a significant increase of 5-HT(7) receptors was found by immunohistochemistry in the ipsilateral dorsal horn of the spinal cord after nerve injury, suggesting a "
pain"-triggered regulation of receptor expression. These results support the idea that the 5-HT(7) receptor subtype is involved in the control of
pain and point to a new potential use of 5-HT(7) receptor agonists for the treatment of
neuropathic pain.